SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-098287
Filing Date
2022-04-07
Accepted
2022-04-07 08:48:57
Documents
15
Period of Report
2022-04-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d347365d8k.htm   iXBRL 8-K 25668
2 EX-99.1 d347365dex991.htm EX-99.1 13455
6 GRAPHIC g347365g0405213937331.jpg GRAPHIC 3142
7 GRAPHIC g347365g0406233033618.jpg GRAPHIC 5932
  Complete submission text file 0001193125-22-098287.txt   181377

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vivo-20220407.xsd EX-101.SCH 2889
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vivo-20220407_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vivo-20220407_pre.xml EX-101.PRE 10834
9 EXTRACTED XBRL INSTANCE DOCUMENT d347365d8k_htm.xml XML 3266
Mailing Address 3471 RIVER HILLS DRIVE CINCINNATI OH 45244
Business Address 3471 RIVER HILLS DR CINCINNATI OH 45244 5132713700
MERIDIAN BIOSCIENCE INC (Filer) CIK: 0000794172 (see all company filings)

IRS No.: 310888197 | State of Incorp.: OH | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-14902 | Film No.: 22812409
SIC: 2835 In Vitro & In Vivo Diagnostic Substances